MINI - SYMPOSIUM
Cancer Immunotherapy
October 28, 2026 • Zoom & In Person
10:00 AM IST
Amity Centre of Translational Research
Amity University - E2 Auditorium
Noida, Uttar Pradesh, India
Jointly Organized By:
SOUTH ASIA CHAPTER
Schedule
10:00 am – 10:05 am
Welcome Address & Introduction of Cancer Immunotherapy Unit
(CIU), Prof. (Dr) Hridayesh Prakash, Director CIU
10:05 am - 10:10 am - Address by Prof. (Dr) B. C. Das
Dean Health and Allied Science & Chairperson
Amity Institute of Molecular Medicine and Stem Cell Research, Amity University Noida
10:10 am - 10:15 am - Address by Prof. (Dr) Chanderdeep Tandon
Additional Pro VC and Dean FBB, Amity University Noida
10.15 am - 10.30 am - Dr. Vivek M. Rangnekar - GCC Founder
Markey Cancer Center, University of Kentucky, USA.
GCC Vision and Organizational Overview
10:30 am – 11:00 am Keynote Speaker - Prof. (Dr) Justin D. Lathia, Director
Cleveland Clinic, Cleveland, Ohio, USA
Title - Sex Differences in the Glioblastoma Immune Response
Neuro-Oncology Program
11:00 am – 11:30 am - Tea Break and Networking
11:30 am – 12:00 pm - Dr. Jayanta Bhattacharya
IIT Delhi
Title – An Agonist-engineered Immunosome Overcomes Associated Toxicities and Provides Relapse-free Survival through Durable Anti-tumor Immunity.
12:00 pm - 12:30 pm - Dr. Sushma Agarwal
SGPGIMS, Lucknow
Title – Consolidation Radiotherapy in Oligo-Persistent Disease in Metastatic Non-Small Cell Lung Cancer Yields Encouraging Results
12:30 pm – 12:40 pm Vote of Thanks, Dr. Monika Bhardwaj, Amity Centre for Translational Research
12:45 pm - Lunch & Departure